−1.52USD
−66.43 MUSD
143.27 MUSD
43.16 M
About BioLife Solutions, Inc.
Sector
Industry
CEO
Roderick de Greef
Website
Headquarters
Bothell
Employees (FY)
414
Founded
1987
FIGI
BBG000HRJ8Q5
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BLFS is 17.10 USD — it has increased by 1.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BioLife Solutions, Inc. stocks are traded under the ticker BLFS.
BioLife Solutions, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
BLFS stock is 5.39% volatile and has beta coefficient of 3.04. Check out the list of the most volatile stocks — is BioLife Solutions, Inc. there?
BLFS earnings for the last quarter are −0.67 USD per share, whereas the estimation was −0.36 USD resulting in a −83.92% surprise. The estimated earnings for the next quarter are −0.34 USD per share. See more details about BioLife Solutions, Inc. earnings.
BioLife Solutions, Inc. revenue for the last quarter amounts to 33.33 M USD despite the estimated figure of 33.01 M USD. In the next quarter revenue is expected to reach 33.40 M USD.
Yes, you can track BioLife Solutions, Inc. financials in yearly and quarterly reports right on TradingView.
BLFS stock has risen by 9.90% compared to the previous week, the month change is a 6.61% fall, over the last year BioLife Solutions, Inc. has showed a 13.15% decrease.
BLFS net income for the last quarter is −13.38 M USD, while the quarter before that showed −29.13 M USD of net income which accounts for 54.06% change. Track more BioLife Solutions, Inc. financial stats to get the full picture.
Today BioLife Solutions, Inc. has the market capitalization of 761.04 M, it has decreased by 1.43% over the last week.
No, BLFS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BLFS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioLife Solutions, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 414.00 employees. See our rating of the largest employees — is BioLife Solutions, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioLife Solutions, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioLife Solutions, Inc. stock shows the sell signal. See more of BioLife Solutions, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BioLife Solutions, Inc. future price: according to them, BLFS price has a max estimate of 30.00 USD and a min estimate of 20.00 USD. Read a more detailed BioLife Solutions, Inc. forecast: see what analysts think of BioLife Solutions, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioLife Solutions, Inc. EBITDA is −44.74 M USD, and current EBITDA margin is −31.58%. See more stats in BioLife Solutions, Inc. financial statements.